Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Franova, M. Joskova, I. Kazimierova, M. Sutovska (Martin, Slovakia). Polyphenolic compounds and experimentally induced allergic asthma. Eur Respir J 2013; 42: Suppl. 57, 869

Member's Comments

No comment yet.

Related content which might interest you: Polyphenolic compounds and experimentally induced allergic asthma Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Investigating antioxidant therapy for steroid-resistant asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Dose-dependent differential effects of thrombin in allergic bronchial asthma Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 The role of monoterpenes derived from essential oils in lung alteration in a model of emphysema Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Evaluation of bronchodilator activity of A. precatorius leaves Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008